Potential therapeutic efficacy of Ukrain (NSC 631570) in AIDS patients with Kaposi's sarcoma

Drugs under Experimental and Clinical Research

Volumn 22, Issue 3-5, 1996, Pages 283-286

  Voltchek, I V ^a   Liepins, A ^b   Nowicky, J W ^c   Brzosko, W J ^d  

^a NORTH WESTERN STATE MEDICAL UNIVERSITY NAMED AFTER I I MECHNIKOV   (Russian Federation)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^c Ukrainian Anti Cancer Institute   (Austria)

^d Roch Brzosko Mem Ctr for Nat Med   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID; NSC 631570; PHOSPHOROTHIOIC ACID; UKRAIN; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE REPORT; DRUG EFFICACY; DRUG TOLERABILITY; HELPER CELL; HEMATOLOGY; HUMAN; HUMAN CELL; IMMUNOLOGY; INTRAVENOUS DRUG ADMINISTRATION; KAPOSI SARCOMA; LEUKOCYTE; LEUKOCYTE COUNT; MALE; SUPPRESSOR CELL; T LYMPHOCYTE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ALKALOIDS; ANTINEOPLASTIC AGENTS; BERBERINE ALKALOIDS; HUMANS; MALE; PHENANTHRIDINES; SARCOMA, KAPOSI;

EID: 0029789537     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Barre-Sinoussi F. et al. Isolation of T-lymphotrophic retrovirus from a patient at risk for acquired immunodeficiency syndrome (AIDS). Science, 220, 868-871, 1983.
2. Clavel F. et al. Isolation of a new human retrovirus from West African patients with AIDS. Science, 233, 343-346, 1986.
3. Cohen J. Somber news from the AIDS front. Science, 260, 1712-1713, 1993.
4. Liepins A., Nowicky J.W. Ukrain is selectively cytostatic and/or cytotoxic to human tumour and HIV-infected cells but not to human normal cells. In: Proceedings 17th International Congress of Chemotherapy, Berlin, 23-28 June, 1991, pp. 2660-2661.
5. Nowicky J.W., Staniszewski A., Zbroja-Sontag W., Slezak B., Nowicky W., Hiesmayr W. Chelidonium majus L. (Ukrain) as an immunostimulant in patients with various carcinomas. Drugs Exptl. Clin. Res., XVII, 139-143, 1991.
6. Nowicky J.W., Manolakis G., Meijer D., Vatanasapt V., Brzosko W.J. Ukrain both as an anticancer and immunoregulatory agent. Drugs. Exptl. Clin. Res., XVIII (Suppl.), 51-54, 1992.
7. Pauwels R. et al. Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives. Nature, 343, 470-474, 1990.
8. Pialoux G. et al. Pharmacokinetics of R 82913 in patients with AIDS or AIDS-related complex. Lancet, 338, 140-143, 1991.
9. Lavie G. et al. Studies of the mechanisms of action of the antiretroviral agents hypericin and pseudohypericin. Proc. Natl. Acad. Sci. USA, 86, 5963-5967, 1989.
10. Numazaki K. et al. Infection of cultured human thymic epithelium cells by human immunodeficiency virus. Clin Immunol. Immunopathol., 51, 185-195, 1989.
11. Davis A.E. Jr. The histopathological changes in the thymus gland in the acquired immunodeficiency syndrome. Ann. N.Y. Acad. Sci., 437, 493-501, 1984.
12. Pluda J.M., Broder S., Yarchoan R. Therapy of AIDS and AIDS-associated neoplasms. In: Pinedo H.M., Longo D.L., Chabner B.A. eds. "Cancer chemotherapy and biological response modifiers." Annual 13. Elsevier Science Publishers, Amsterdam, 1992.
13. Pantaleo G., Graziosi C., Gauci A.S. New concepts in immunopathogenesis of human immunodeficiency virus infection. N. Engl. J. Med., 328, 327-335, 1993.
14. Lotze M.T. et al. In vitro administration of purified human interleukin 2. II. Half life, immunologic effects and expansion of peripheral lymphoid cells in vivo with recombinant IL-2. J. Immunol., 135, 2865-2875, 1985.
15. Urba W.J., Longo D.L. α-Interferon in the treatment of nodular lymphomas. Semin. Oncol., 13 (Suppl. 5), 40-47, 1986.
16. Humphries M.J., Matsumoto K., White S.L., Molyneux R.J., Olden K. Augmentation of murine natural killer cell activity of swainsonine, a new antimetastatic immunomodulator. Cancer Res., 48, 1410-1415, 1988.
17. Mohla S. et al. Inhibition of growth of subcutaneous xenografts and metastasis of human breast carcinoma by swainsonine: modulation of tumor cell HLA class I antigens and host immune effector mechanisms. Anticancer Res., 10, 1515-1522, 1990.